AMIORG Stock Overview
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Ami Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,524.85 |
| 52 Week High | ₹2,644.00 |
| 52 Week Low | ₹1,004.45 |
| Beta | -0.063 |
| 1 Month Change | 14.17% |
| 3 Month Change | 23.84% |
| 1 Year Change | 128.13% |
| 3 Year Change | 162.17% |
| 5 Year Change | n/a |
| Change since IPO | 170.04% |
Recent News & Updates
Ami Organics Limited (NSE:AMIORG) Looks Just Right With A 27% Price Jump
Feb 06
Revenue Beat: Ami Organics Limited Beat Analyst Estimates By 11%
Jan 31Recent updates
Ami Organics Limited (NSE:AMIORG) Looks Just Right With A 27% Price Jump
Feb 06Revenue Beat: Ami Organics Limited Beat Analyst Estimates By 11%
Jan 31Why Investors Shouldn't Be Surprised By Ami Organics Limited's (NSE:AMIORG) 30% Share Price Surge
Nov 07Market Participants Recognise Ami Organics Limited's (NSE:AMIORG) Revenues Pushing Shares 26% Higher
Sep 22We Think The Compensation For Ami Organics Limited's (NSE:AMIORG) CEO Looks About Right
Sep 14Ami Organics (NSE:AMIORG) Is Due To Pay A Dividend Of ₹3.00
Sep 02Ami Organics Limited (NSE:AMIORG) Not Lagging Industry On Growth Or Pricing
Jun 24Earnings Troubles May Signal Larger Issues for Ami Organics (NSE:AMIORG) Shareholders
May 21Ami Organics Limited Recorded A 7.8% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 15We Think That There Are Some Issues For Ami Organics (NSE:AMIORG) Beyond Its Promising Earnings
May 24Analysts Have Made A Financial Statement On Ami Organics Limited's (NSE:AMIORG) Annual Report
May 20Ami Organics Limited's (NSE:AMIORG) Earnings Haven't Escaped The Attention Of Investors
Apr 01Shareholder Returns
| AMIORG | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 7.0% | 3.2% | 2.4% |
| 1Y | 128.1% | 18.4% | 5.8% |
Return vs Industry: AMIORG exceeded the Indian Pharmaceuticals industry which returned 18.4% over the past year.
Return vs Market: AMIORG exceeded the Indian Market which returned 5.8% over the past year.
Price Volatility
| AMIORG volatility | |
|---|---|
| AMIORG Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: AMIORG's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: AMIORG's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 676 | Naresh Patel | www.amiorganics.com |
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries.
Ami Organics Limited Fundamentals Summary
| AMIORG fundamental statistics | |
|---|---|
| Market cap | ₹103.35b |
| Earnings (TTM) | ₹1.21b |
| Revenue (TTM) | ₹9.23b |
85.1x
P/E Ratio11.2x
P/S RatioIs AMIORG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMIORG income statement (TTM) | |
|---|---|
| Revenue | ₹9.23b |
| Cost of Revenue | ₹5.29b |
| Gross Profit | ₹3.94b |
| Other Expenses | ₹2.73b |
| Earnings | ₹1.21b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 29.65 |
| Gross Margin | 42.72% |
| Net Profit Margin | 13.15% |
| Debt/Equity Ratio | 0.5% |
How did AMIORG perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield26%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 18:06 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ami Organics Limited is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Prashant Nair | Ambit Capital |
| Nitin Bhasin | Ambit Capital |
| Amey Chalke | Haitong International Research Limited |